Wired AI
·
1 day ago
Hemispheric, founded by an Apple FaceID co-inventor, raised $52 million to develop AI models that diagnose cognitive disorders by analyzing brain electrical activity from EEG headsets. The startup trained its deep-learning model on 250,000 hours of brain data collected from 100,000 people and plans to submit its first product for PTSD diagnosis to the FDA in early 2025, with public availability targeted for late 2027. The approach aims to replace subjective questionnaires with objective AI-assisted diagnosis that could eventually function as simply and cheaply as a blood test.
NVIDIA
·
1 day ago
NVIDIA and Japanese partners are deploying AI technology across healthcare, robotics, vision systems, and financial services, with pharma companies using NVIDIA BioNeMo for drug discovery, medical device makers building surgical robots, and banks like Mizuho planning large on-premises AI factories. Mizuho is building what is expected to be Japan's largest on-premises AI factory for the financial industry starting with DGX B200 systems, while companies like Biomy achieved 90% faster spatial transcriptomics analysis using NVIDIA single-cell RAPIDS. These deployments represent a shift from experimental AI to production infrastructure across Japanese industry, with NVIDIA technology integrated into core workflows for drug discovery, medical imaging, industrial inspection, and financial services.
